Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 108.35 -6.31 (5.5%)
Previous Close $114.66    52 Week High $ 
Open $114.80    52 Week Low $ 
Day High $116.69    P/E N/A 
Day Low $107.11    EPS $ 
Volume 431,273